Back to Index
Grace Marianne Facio
Rn, Bsn, Ocn, Research Nurse
Cancer Center
IRD 525 Off Campus Los Angeles
+1 323 226 7027


Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer. Cancer Invest. 2012 May; 30(4):295-9. View in: PubMed

Roman LD, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2007 Sep; 106(3):558-66. View in: PubMed

Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. View in: PubMed

Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. View in: PubMed

HUME JC, FACIO G. An analysis of the results of the treatment of yaws with a single injection of procaine penicillin with 2% aluminium monostearate. Bull World Health Organ. 1956; 15(6):1057-85. View in: PubMed

Powered bySC CTSI